am 251 and jzl195

am 251 has been researched along with jzl195 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, WB; Gould, MJ; Mitchell, VA; Torres, RD; Vaughan, CW1
Crews, FT; Grant, ML; Jones, VM; Khatri, D; Laroche, G; Mukhopadhyay, S; Vetreno, RP1

Other Studies

2 other study(ies) available for am 251 and jzl195

ArticleYear
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.
    Neuropharmacology, 2014, Volume: 81

    Topics: Amidohydrolases; Analgesics; Analysis of Variance; Animals; Arthritis, Experimental; Benzamides; Benzoxazines; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Time Factors

2014
Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling.
    Alcoholism, clinical and experimental research, 2018, Volume: 42, Issue:4

    Topics: Animals; Binge Drinking; Cannabinoids; Carbamates; Caspase 3; Cell Death; Cell Proliferation; Doublecortin Domain Proteins; Doublecortin Protein; Drug Interactions; Endocannabinoids; Ethanol; Hippocampus; Ki-67 Antigen; Male; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Piperazines; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant

2018
chemdatabank.com